Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;51(8):2580-2586.
doi: 10.1161/STROKEAHA.120.030417. Epub 2020 Jun 24.

National Institutes of Health StrokeNet During the Time of COVID-19 and Beyond

Affiliations

National Institutes of Health StrokeNet During the Time of COVID-19 and Beyond

Joseph P Broderick et al. Stroke. 2020 Aug.
No abstract available

Keywords: United States; biomarkers; data management; therapeutics.

PubMed Disclaimer

References

    1. Broderick JP, Palesch YY, Janis LS; National Institutes of Health StrokeNet Investigators. The National Institutes of Health StrokeNet: a user’s guide. Stroke. 2016; 47:301–303. doi: 10.1161/STROKEAHA.115.011743 - PMC - PubMed
    1. Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018; 379:215–225. doi: 10.1056/NEJMoa1800410 - PMC - PubMed
    1. Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL; Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial. JAMA. 2019; 322:326–335. doi: 10.1001/jama.2019.9346 - PMC - PubMed
    1. Lyden P, Pryor KE, Coffey CS, Cudkowicz M, Conwit R, Jadhav A, Sawyer RN, Jr, Claassen J, Adeoye O, Song S, et al. ; NeuroNEXT Clinical Trials Network NN104 Investigators. Final results of the RHAPSODY trial: a multi-center, phase 2 trial using a continual reassessment method to determine the safety and tolerability of 3K3A-APC, a recombinant variant of human activated protein C, in combination with tissue plasminogen activator, mechanical thrombectomy or both in moderate to severe acute ischemic stroke. Ann Neurol. 2019; 85:125–136. doi: 10.1002/ana.25383 - PMC - PubMed
    1. Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, Mayo SW, Bistran-Hall AJ, Gandhi D, Mould WA, et al. ; MISTIE III Investigators. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019; 393:1021–1032. doi: 10.1016/S0140-6736(19)30195-3 - PMC - PubMed